Pharmacokinetics of Mirodenafil and Its Two Metabolites, SK3541 and SK3544, in Spontaneously or DOCA-Salt-Induced Hypertensive Rats

Pharmacokinetic Interaction between Itraconazole and Metformin in Rats: Competitive Inhibition of Metabolism of Each Drug by Each Other via Hepatic and Intestinal CYP3A1/2

Pharmacokinetics of Oltipraz and Its Major Metabolite (RM) in Patients With Liver Fibrosis or Cirrhosis: Relationship With Suppression of Circulating TGF-beta 1

Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats

Pharmacokinetics and first-pass effects of epsilon-acetamidocaproic acid after administration of zinc acexamate in rats

Pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous and oral administration of mirodenafil to streptozotocin-induced diabetes mellitus rats

Pharmacokinetics of Itraconazole in Diabetic Rats

Pharmacokinetics of mirodenafil, a new erectogenic, and its metabolite, SK3541, in rats: involvement of CYP1A1/2, 2B1/2, 2D subfamily, and 3A1/2 for the metabolism of both mirodenafil and SK3541

Slower clearance of intravenous metformin in rats with acute renal failure induced by uranyl nitrate: Contribution of slower renal and non-renal clearances

Dose-Dependent Pharmacokinetics of SP-8203 in Rats